News of the Day

PEFO confirms MA secured ATAGI fee delay April 18, 2019

The Pre-election Economic and Fiscal Outlook has confirmed the delay in the implementation of the new $300,000 fee for vaccine submissions to ATAGI.

More intervention may be needed on gene therapies April 16, 2019

Novartis has the existing organisational capacity to support the Australian commercialisation of a gene therapy like KYMRIAH - and it was still very hard - many companies developing similar treatments have virtually no presence in Australia.

Another HCV blow as MSD pulls promotion April 15, 2019

The company attributed its decision to the dramatic decline in the uptake of the direct-acting antivirals and "reimbursement pricing caps based on unreasonable patient numbers" and large and unsustainable rebates.

It might be caretaker but the announcements may not be over April 12, 2019

The caretaker period relates to the making of decisions and not announcements. Ministers, including health minister Greg Hunt, are still free to announce decisions taken in recent days and weeks.

MA secures major commitments from Greg Hunt April 11, 2019

Some important gains for Medicines Australia with the industry securing significant political commitments from health minister Greg Hunt as the government prepares to call an election.

Some nerves over cost-recovery regulations April 10, 2019

The regulations giving effect to new PBS cost-recovery arrangements have been tabled but the industry is understood to have secured a commitment for a 12-month delay in the implementation of a $300,000 fee for vaccines.

The 'Value in Prescribing' program targeting bDMARDs April 9, 2019

The government has opened a new front on utilisation with over $8 million set aside for a program promoting patient use of the "lowest priced bDMARDs".

MA calls for urgent political intervention on new criteria April 8, 2019

The industry has provided significant feedback on new criteria for special pricing arrangements despite claims by a senior Department of Health official.

MA welcomes Labor's cancer pledge April 5, 2019

Labor has committed to a dramatic expansion in Medicare for cancer and restated its committed to list on the PBS every medicine recommended by the PBAC.

Budget 'surprise' as rebate revenue goes to 'zero' April 4, 2019

The Budget has revealed the government's surprise system-wide plan to eliminate all PBS revenue - even that paid under agreements not relating to special pricing arrangements - adding hundreds of millions to the topline reduction in PBS spending.

Subtle but important change in new listing claim April 2, 2019

The government now says new 'items' rather than new 'medicines' when it describes how many things it has added to the PBS since 2013.

No DHL in new CSO contracts April 1, 2019

Confirmation of the new contracts has revealed no DHL with exclusive direct distribution arrangements set to remain an ongoing controversy.

Latest Video

Most Read

New Stories

PEFO confirms MA secured ATAGI fee delay

'Right to Trial' in blood cancers-a limited version of Trump's 'Right to Try'

MA starts communication on 'principles' Code

Pfizer goes red for World Haemophilia Day

Labor commits to 'early access' trials

AusBiotech laments 'wearisome' uncertainty over fate of R&D tax incentive

Jacinda Ardern: 'Work to be done' on PHARMAC

Sign In